Curis | CRIS - Interest Expense On Debt


Curis reported $178K in Interest Expense on Debt for its fiscal quarter ending in December of 2023.





Interest Expense On Debt Change Date
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Amgen USD 657M 4M Mar/2026
AstraZeneca USD 484M 181M Dec/2025
Bayer EUR 675M 87M Dec/2025
Bristol-Myers Squibb USD 411M 21M Mar/2026
CSL USD 215M 111M Dec/2025
Curis USD 178K 441K Dec/2023
Eli Lilly USD 114.7M 134.3M Sep/2025
Exelixis USD 23.4M 3.9M Sep/2023
Gilead Sciences USD 240M 15M Mar/2026
GlaxoSmithKline GBP 167M 21M Mar/2026
Incyte USD 569K 13K Mar/2026
Merck USD 479M 67M Mar/2026
Novartis USD 343M 39M Mar/2026
Pfizer USD 671M 40M Mar/2026
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 178M 203M Mar/2026
Takeda JPY 43.65B 79.98B Mar/2026
TG Therapeutics USD 7.67M 1.13M Mar/2026
Verastem USD 415K 733K Dec/2025